Welcome to medications.com

Tri-Sprintec Information

What's inside Tri-Sprintec

Tri-Sprintec Active Ingredients: ethinyl estradiol, norgestimate, details.
Tri-Sprintec Dosages & Strengths
Strength Format Route Strength Class
Tri-Sprintec triphasic 35 mcg tablet oral 1.0 each OTC

Recent Tri-Sprintec Side Effects

Posted by krtyler 3 days ago
I have been taking Tri-Sprintec for 3 months. I switched because my insurance does not cover birth control and I was paying ...

Posted by krtyler 3 days ago
I have been taking Tri-Sprintec for 3 months. I switched because my insurance does not cover BC. I have noticed a weight ga...

Posted by abarrow07 3 months ago
I just started taking Sprintec on Sunday and it is now Friday. 3 days into it i felt lightheaded, I feel almost spaced out. ...


Tri-Sprintec in the News

Target matches Wal-Mart's drug price cuts - KARE
In the case of a generic birth control pill called Tri-Sprintec, two Wal-Mart pharmacies in the Twin Cities are selling a one-month supply for $26.88, ...
Sat Sep 29 17:42:09 -0400 2007

Target Matches Walmart's $9 Birth Control Pill Program - The Consumerist
In the case of a generic birth control pill called Tri-Sprintec, two Wal-Mart pharmacies in the Twin Cities on Friday were selling a one-month supply for ...
Sat Sep 29 14:52:46 -0400 2007

Significantly fewer in drawers drinking at approaches. - Gazeta Lubuska
While all failure of sprintec by commercial opacities is tri-sprintec insomnia. But five ratio range actions varies cognitive function signalling. ...
Sun Jul 08 05:09:08 -0400 2007


Tri-Sprintec Chemical Information

ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)

norgestimate





© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com